The 7th Annual Drug Repositioning, Repurposing and Rescue Conference - Academic/Government/Non-Profit (Chicago, United States - June 26-27, 2018) -

The 7th Annual Drug Repositioning, Repurposing and Rescue Conference in Chicago is where attendees will meet and learn from the world's foremost experts in the fields of repositioning and repurposing.

Why Attend

As the Single Longest-Running Conference in the Space, this annual event continues to be the go to meeting for pharma executives, academicians, researchers and patient advocacy groups who want to keep abreast of new developments in the field, learn from experts and meet possible collaborators and partners. The agenda incorporates Case Studies, Genetics/Genomics, new Cutting-Edge Technology (including artificial intelligence), Regulatory Guidance, Big Data Approaches, New Drug Discovery Paradigms, Partnering Models, Crowdsourcing Methods and repurposing projects for Rare/Orphan Diseases, Tropical Diseases, Cancer and many other diseases and conditions.

Key Themes

  • Patient Advocacy Efforts
  • New Partnerships
  • Commercial Case Studies
  • Collaborative Efforts
  • Systematic Repositioning And Data Analytics


1. Open Innovation - A Driver for Drug Repositioning

2. Repositioning is Easy - Or Is It? The impact of AI on Future Progress

3. Leveraging Human Genetics to Repurpose Drugs: Lessons Learned

4. Using Artificial Intelligence to Identify Potential Drug Repurposing Opportunities

5. Application of In Silico Proteome Screening to Discover a Drug's Polypharmacology to Facilitate Drug Repurposing

6. Nutraceuticals as Repositioning Agents: Rapid Acceleration from Bench to Clinical Trial

7. A Systems Biology Driven Repositioning Strategy Identifies Digoxin for Treating Groups 3 and 4 Medulloblastoma

8. A Systems Medicine Approach to Drug Repurposing

9. Systematic Drug (Re)Purposing by Triangulating Insights from Unstructured and Structured Data Using Machine Learning

10. Expanding the Impact of Repurposing Research

11. Repurposing Low-dose Methotrexate for the Treatment of Myeloproliferative Disease

12. Multi-orthogonal Disruptive Integration (MODI) to Teach Old Drugs New Tricks

13. Big Data-based Drug Repurposing Strategy: Special Focus on Brain Ischemia

For more information about this conference visit

Back to news